Yao Caroline A, Ellis Chandra V, Cohen Myles J, Kulber David A
Plastic Surgery Center, Cedars Sinai Medical Center, and Division of Plastic and Reconstructive Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, Calif.
Plast Reconstr Surg Glob Open. 2013 Nov 7;1(7):e65. doi: 10.1097/GOX.0b013e3182aa8793. eCollection 2013 Oct.
Advanced thumb carpometacarpal arthritis is widely treated with trapeziectomy and tendon interposition despite donor-site morbidities. Trapeziectomy alone leaves a postresection space, leading to proximal metacarpal migration and scaphoid/trapezoid impingement. Prosthetic implants have been unsuccessful due to particulate debris, silicone synovitis, osteolysis, and migration. Recent studies have shown successful use of allograft for interposition material in the posttrapeziectomy space both in animal and human models. To obviate the need for autologous tissue, maintain thumb length, and reduce the risk of scaphoid impingement, the senior author developed an interposition arthroplasty technique using a spacer constructed from human acellular dermal matrix (HADM).
Sixteen patients with Eaton stage III-IV thumb carpometacarpal osteoarthritis received the above procedure from the 2 senior authors. HADM was imbricated to fill the posttrapeziectomy space and secured to the volar capsule and metacarpal base. Pre- and postoperative trapezial space on radiograph, pain scores, and grip strength were recorded.
Six months postoperatively, radiographs showed an average joint space loss of 11%. Heights postoperatively were not significantly different from immediate postoperative heights (P ≥ 0.01). At 6 months, patients had improved pain and grip strength (P ≤ 0.01). No infections, foreign body reactions, or other complications occurred.
HADM has been used extensively in other forms of reconstruction and has been shown to incorporate into surrounding tissues through neovascularization. Our early results illustrate that HADM can safely fill the dead space left by trapeziectomy.
尽管存在供区并发症,但晚期拇指腕掌关节炎仍广泛采用大多角骨切除术和肌腱间置术进行治疗。单纯大多角骨切除术会留下切除后间隙,导致第一掌骨近端移位和舟骨/小多角骨撞击。由于颗粒碎片、硅酮滑膜炎、骨质溶解和移位,假体植入一直未取得成功。最近的研究表明,在动物和人体模型中,同种异体移植物成功用于大多角骨切除术后间隙的间置材料。为避免使用自体组织的需求、维持拇指长度并降低舟骨撞击的风险,资深作者开发了一种使用由人脱细胞真皮基质(HADM)构建的间隔物的间置关节成形术技术。
16例伊顿III-IV期拇指腕掌骨关节炎患者接受了上述两位资深作者实施的手术。将HADM重叠以填充大多角骨切除术后间隙,并固定于掌侧关节囊和掌骨基部。记录术前和术后X线片上的大多角骨间隙、疼痛评分和握力。
术后6个月,X线片显示平均关节间隙损失11%。术后高度与术后即刻高度无显著差异(P≥0.01)。在6个月时,患者的疼痛和握力有所改善(P≤0.01)。未发生感染、异物反应或其他并发症。
HADM已广泛应用于其他形式的重建手术,并已证明可通过新生血管形成融入周围组织。我们的早期结果表明,HADM可安全填充大多角骨切除术留下的死腔。